Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

28

Number of overlapping holdings

65.1%

% of CANC's 43 holdings also in IBB

13.8%

% of IBB's 223 holdings also in CANC

Overlap by Weight
Sector Drift (CANC minus IBB)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in CANC
Weight
in IBB
Overlap
REGENERON PHARMACEUTICALS 5.5% 8.8% 5.5%
GILEAD SCIENCES INC 2.8% 7.1% 2.8%
ILLUMINA INC 3.6% 2.1% 2.1%
ARGENX SE ADR 3.0% 1.7% 1.7%
MODERNA, INC. 1.7% 3.2% 1.7%

Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to IBB
MERCK & CO. INC. 5.2%
DAIICHI SANKYO CO LTD 3.9%
NOVARTIS AG 3.7%
ASTRAZENECA PLC 3.2%
CHUGAI PHARMACEUTICAL CO LTD 2.8%
CRISPR THERAPEUTICS AG 2.7%
CELLDEX THERAPEUTICS INC 2.4%
BRISTOL-MYERS SQUIBB CO 2.3%
GUARDANT HEALTH, INC. 2.2%
REVOLUTION MEDICINES, INC. 2.0%
CANC Underweight Relative to IBB
VERTEX PHARMACEUTICALS INC -9.0%
AMGEN INC -7.9%
IQVIA HOLDINGS INC -4.3%
GILEAD SCIENCES INC -4.3%
REGENERON PHARMACEUTICALS -3.3%
BIOGEN IDEC INC -3.2%
METTLER-TOLEDO INTERNATIONAL -2.6%
ALNYLAM PHARMACEUTICALS INC -2.0%
WATERS CORP -1.9%
BIOMARIN PHARMACEUTICAL INC -1.7%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY